Actively Recruiting
Personalizing Financial Incentives
Led by University of Utah · Updated on 2026-03-06
80
Participants Needed
1
Research Sites
55 weeks
Total Duration
On this page
Sponsors
U
University of Utah
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to determine the feasibility of providing personalized incentives for dietary self-monitoring and/or interim weight loss to people enrolled in a weight-loss program
CONDITIONS
Official Title
Personalizing Financial Incentives
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing to attend virtual baseline and follow-up data collection visits
- At least 18 years of age
- Verified obesity as defined as a BMI 630 kg/m2
- Agree to attend 13 biweekly group classes (virtual) delivered by a registered dietitian
- Agree to review study materials between classes
- Regular access to an unshared smart phone
- Reliable access to internet
- Able to speak and read English
- Desire to lose weight
- Able to connect to a video conference call using a smartphone, tablet or computer with a webcam and microphone
- Ability to download and use Fitbit app daily
- Have or be willing to create a Gmail address
- Physical ability to stand on a scale without support
You will not qualify if you...
- Weight loss of at least 10lbs in the month prior to screening
- Weight > 380lbs
- Currently enrolled or enrolled in the previous month in a clinical, research, or community program focusing on lifestyle change that could affect weight
- New user of weight loss medication
- Pregnant, lactating or planning on becoming pregnant during the study
- History of bariatric procedure or planning to have bariatric procedure in the study timeframe
- Residing in a nursing home, skilled nursing facility or assisted living facility
- Impaired hearing
- Significant dementia, drug or alcohol abuse, or unstable psychiatric illness (e.g., schizophrenia, psychosis)
- Current treatment for cancer or being treated for cancer (besides basal cell carcinoma or squamous cell) in the last 6 months
- Use of insulin, sulfonylureas, or meglitinides due to increased risk for hypoglycemia
- Diuretic medication doses higher than hydrochlorothiazide or chlorthalidone 25 mg daily, furosemide 40 mg daily, torsemide 20 mg daily, bumetanide 1 mg daily, or any use of metolazone; use of potassium-sparing diuretics is acceptable
- Unstable heart disease in the 6 months prior to screening
- Chronic kidney disease at stage 4 or higher
- Exertional chest pain
- Pain, fainting, or other conditions that prohibit mild/moderate exercise
- History of ascites requiring paracentesis
- Inducing vomiting to prevent weight gain or counteract the effects of eating an average of 1 time per week or more in the past 3 months*
- Not suitable for study participation due to other reasons at the discretion of the investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Utah
Salt Lake City, Utah, United States, 84108
Actively Recruiting
Research Team
C
Corrine Voils, PhD
CONTACT
F
Fiona Robertson
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here